Our commitment to fostering a culture of open communication and collaboration is exemplified through our annual global engagement survey results.
Our safety measures led to a decline in our number of accidents with absence, from 6 in 2022 to 3 in 2023.
Embracing a multi-dimensional perspective, we acknowledge diversity in terms of physical, psychological, social, lifestyle, and cognitive dimensions, actively engaging with a number of employee focus groups to seek input on improving inclusion across ALK.
Value chain workers
ALK's Third-party Code of Conduct outlines the standards of behavior that we expect from all third parties globally when it comes to business conduct and treatment of employees. The Third-party Code of Conduct is an integrated part of our GxP (good practice) supplier agreements.
To address supplier risk, we utilize an external supplier evaluation platform to identify environment, labor & human rights, and procurement risks. 400+ suppliers approved for our GxP processes have been screened, none of which have been identified as high-risk.
Consumers and end users
Safety of people with allergies
ALK has a rigorous safety reporting system in place ensuring that safety data from any source, including clinical trials, are collected and analysed systematically by our global pharmacovigilance team. This ensures that the safety profile of our products is optimized for the benefit of users, and that the relevant authorities can be made aware of any safety issue arising from our products to facilitate immediate action.
Education of healthcare professionals
We engage systematically in educational activities, training and dialogue with healthcare professionals to elevate the standard of care in allergy diagnosis and treatment. Much of our engagement is done digitally enabling us to reach more healthcare professionals and reduce our climate impact.